RHB ascribe 25x CY25E P/E to derive a FV of MYR0.35. The ascribed P/E is above the global IVF service provider average of 21x, premised on ALPHA’s superior margin profile and its opportunity to ride on the trend of declining birth rates in key operating markets, ie Malaysia and Singapore.